Use of simeprevir following pre-emptive pegylated interferon/ribavirin treatment for recurrent hepatitis C in living donor liver transplant recipients: a 12-week pilot study

Directly Acting Antivirals (DAAs) for the Treatment of Chronic Hepatitis C Virus Infection in Liver Transplant Patients: “A Flood of Opportunity”

(2014) E. J. Gane et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Telaprevir with peginterferon/ribavirin for retreatment of null responders with advanced fibrosis post-orthotopic liver transplant

(2014) Paul Y. Kwo et al.   CLINICAL TRANSPLANTATION

New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges

(2014) Jean–Michel Pawlotsky   GASTROENTEROLOGY

Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection

(2014) Hiromitsu Kumada et al.   HEPATOLOGY

Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation

(2014) Tomokazu Kawaoka et al.   HEPATOLOGY RESEARCH

Once-daily simeprevir with peginterferon and ribavirin for treatment-experienced HCV genotype 1-infected patients in Japan: the CONCERTO-2 and CONCERTO-3 studies

(2014) Namiki Izumi et al.   JOURNAL OF GASTROENTEROLOGY

Simeprevir with peginterferon/ribavirin for treatment-naïve hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial

(2014) Norio Hayashi et al.   JOURNAL OF HEPATOLOGY

Impact of Donor and Recipient Single Nucleotide Polymorphisms of IL28B rs8099917 in Living Donor Liver Transplantation for Hepatitis C

(2014) Nobuhiro Harada et al.   PLoS One

Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting

(2013) Sarah Tischer et al.   JOURNAL OF HEPATOLOGY

Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience

(2013) Audrey Coilly et al.   JOURNAL OF HEPATOLOGY

Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation

(2013) Surakit Pungpapong et al.   LIVER TRANSPLANTATION

Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patients

(2013) Stefania Paolucci et al.   Virology Journal

Virological response for recurrent hepatitis C improves long-term survival in liver transplant recipients

(2012) Tomohiro Tanaka et al.   TRANSPLANT INTERNATIONAL

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

(2011) Marc G. Ghany et al.   HEPATOLOGY

Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation

(2010) P. Guillouche et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435

(2010) O. Lenz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Revised Equations for Estimated GFR From Serum Creatinine in Japan

(2009) Seiichi Matsuo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Pre-emptive antiviral therapy in living donor liver transplantation for hepatitis C: observation based on a single-center experience

(2009) Sumihito Tamura et al.   TRANSPLANT INTERNATIONAL

Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin

(2008) Marina Berenguer   JOURNAL OF HEPATOLOGY